United States News All stories

Cadeler (NYSE:CDLR) reported first-half 2026 revenue of EUR 408 million, an increase of EUR 220 million from the adjusted prior-year period, as the offshore wind installation company expanded fleet activity and contracted days.

Rhythm Pharmaceuticals (NASDAQ:RYTM) received Japanese marketing authorization for its IMCIVREE therapy, targeting a company-estimated 5,000 to 8,000 obesity patients.

NVIDIA (NASDAQ:NVDA) placed its Groq 3 LPX AI inference accelerator into full production to process agentic workloads at 3,400 tokens per second.

Boeing (NYSE:BA) engineers and technical workers rejected a four-year contract offer from the company, with members of the Society of Professional Engineering Employees in Aerospace authorizing a potential strike after the contract expires in October.

Tesla (NASDAQ:TSLA) announced plans to unveil the production version of its Cybercab robotaxi at a launch event in Austin, Texas, on September 3.

REGENXBIO (NASDAQ:RGNX) reported that the U.S. Food and Drug Administration placed a clinical hold on its investigational MPS II gene therapy RGX-121 following spine MRI findings in five participants in the CAMPSIITE study.

Monte Rosa Therapeutics (NASDAQ:GLUE) announced that the first patient has been dosed in MODeFIRe-1, a Phase 2 trial evaluating investigational molecular glue degrader MRT-2359 with apalutamide in patients with AR mutation-positive metastatic castration-resistant prostate cancer.

VERAXA Biotech (NASDAQ:VRXA) and Secarna Pharmaceuticals announced a research milestone in their collaboration to develop antibody-oligonucleotide conjugates for autoimmune and chronic immune diseases.

Philip Morris International (NYSE:PM) announced that its non-U.S. affiliates entered a contract manufacturing arrangement with Philip Morris USA, an operating company of Altria (NYSE:MO), for combustible cigarettes.

TwinStrand Biosciences announced that the U.S. District Court for the District of Delaware entered final judgment in favor of TwinStrand and the University of Washington in their patent infringement case against Guardant Health (NASDAQ:GH), awarding more than $245.2 million in damages, royalties, and interest.

Booz Allen Hamilton (NYSE:BAH) completed its previously announced $720 million acquisition of Ultra I&C Mission Solutions, expanding its defense technology capabilities for national security customers.

H.B. Fuller (NYSE:FUL) announced that its board rejected Ancora’s unsolicited, non-binding proposal to acquire its Building Adhesives Solutions business, stating that the offer undervalues the segment.

Spruce Biosciences (NASDAQ:SPRB) announced that it completed two pre-BLA meetings with the U.S. Food and Drug Administration supporting its planned submission of a Biologics License Application for tralesinidase alfa enzyme replacement therapy in Sanfilippo Syndrome Type B.

The9 (NASDAQ:NCTY) reported unaudited net income of US$32 million for the quarter ended June 30, 2026, up more than 39% from the previous quarter, driven mainly by fair-value recognition of 9BIT tokens.

Insmed (NASDAQ:INSM) announced that Japan’s Ministry of Health, Labour and Welfare approved BRINSUPRI (brensocatib 25 mg) for adults and pediatric patients aged 12 years and older with non-cystic fibrosis bronchiectasis.

BriaCell (NASDAQ:BCTX) announced that Bria-MEL+ has passed a key genetic engineering milestone, moving the personalized whole-cell melanoma immunotherapy vaccine candidate toward potential clinical development.

Vanda Pharmaceuticals (NASDAQ:VNDA) announced that the European Commission granted orphan designation to imsidolimab for the treatment of generalized pustular psoriasis, following a positive opinion from the EMA Committee for Orphan Medicinal Products.

NAPCO Security Technologies (NASDAQ:NSSC) reported fiscal Q4 2026 revenue of $55.8 million, up 10% year-over-year, driven by growth in recurring service and equipment revenue.

Scinai Immunotherapeutics (NASDAQ:SCNI) reported first-half 2026 revenue of $949 thousand, up from $773 thousand a year earlier, driven mainly by its acquired Yavne contract development and manufacturing organization operations.

Martin Marietta (NYSE:MLM) completed its previously announced combination with Lhoist North America, a subsidiary of Lhoist Group, effective August 21, 2026.

Gogoro (NASDAQ:GGR) reported Q2 2026 revenue of $70.6 million, up 7.3% year-over-year, supported by higher hardware and other revenue.

nVent (NYSE:NVT) agreed to acquire Maverick Power for $1.75 billion, subject to customary adjustments, in a transaction aimed at expanding its power distribution and infrastructure solutions business.

PDD Holdings (NASDAQ:PDD) reported Q2 2026 revenue of RMB112.4 billion (US$16.6 billion), up 8% year-over-year, supported mainly by higher transaction services revenue.

XPENG (NYSE:XPEV) reported a second-quarter total revenue of RMB19.74 billion (US$2.91 billion) driven by strong vehicle sales.